Last reviewed · How we verify
Active topical NS2 1% dermatologic cream
Active topical NS2 1% dermatologic cream works by targeting the underlying cause of inflammation in the skin.
Active topical NS2 1% dermatologic cream works by targeting the underlying cause of inflammation in the skin. Used for Treatment of dry eye disease.
At a glance
| Generic name | Active topical NS2 1% dermatologic cream |
|---|---|
| Sponsor | Aldeyra Therapeutics, Inc. |
| Drug class | Topical anti-inflammatory |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 2 |
Mechanism of action
The exact molecular target of NS2 is not well-documented, but it is believed to modulate the immune response and reduce inflammation in the skin. This is achieved through a complex interplay of cellular and molecular mechanisms that are not yet fully understood.
Approved indications
- Treatment of dry eye disease
Common side effects
- Eye irritation
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: